ES2033341T3 - Uso de la l-carnitina en el tratamiento de los efectos toxicos inducidos por inhalacion de halotane y otros anestesicos generales conteniendo halogenos. - Google Patents

Uso de la l-carnitina en el tratamiento de los efectos toxicos inducidos por inhalacion de halotane y otros anestesicos generales conteniendo halogenos.

Info

Publication number
ES2033341T3
ES2033341T3 ES198787830246T ES87830246T ES2033341T3 ES 2033341 T3 ES2033341 T3 ES 2033341T3 ES 198787830246 T ES198787830246 T ES 198787830246T ES 87830246 T ES87830246 T ES 87830246T ES 2033341 T3 ES2033341 T3 ES 2033341T3
Authority
ES
Spain
Prior art keywords
halotane
carnitine
inhalation
halogenes
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787830246T
Other languages
English (en)
Inventor
Noris Siliprandi
Guido Scutari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2033341T3 publication Critical patent/ES2033341T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA ADMINISTRACION POR VIA ORAL O PARENTERAL DE 10 A 30 MG/KG/DIA DE L-CARNITINA (O UNA CANTIDAD EQUIVALENTE DE UNA SAL DE LA MISMA FARMACOLOGICAMENTE ACEPTABLE), TANTO DURANTE LA FASE DE PREANESTESIA COMO DURANTE LA FASE POSTOPERATORIA, ANTAGONIZA LOS EFECTOS TOXICOS (PARTICULARMENTE SOBRE LOS RI/ONES Y EL HIGADO) INDUCIDOS POR LA INHALACION DE ANESTESICOS GENERALES QUE CONTIENEN HALOGENO, TALES COMO, TIPICAMENTE, EL HALOTANO.
ES198787830246T 1986-07-04 1987-07-01 Uso de la l-carnitina en el tratamiento de los efectos toxicos inducidos por inhalacion de halotane y otros anestesicos generales conteniendo halogenos. Expired - Lifetime ES2033341T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48228/86A IT1195852B (it) 1986-07-04 1986-07-04 Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati

Publications (1)

Publication Number Publication Date
ES2033341T3 true ES2033341T3 (es) 1993-03-16

Family

ID=11265360

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787830246T Expired - Lifetime ES2033341T3 (es) 1986-07-04 1987-07-01 Uso de la l-carnitina en el tratamiento de los efectos toxicos inducidos por inhalacion de halotane y otros anestesicos generales conteniendo halogenos.

Country Status (7)

Country Link
US (1) US4780308A (es)
EP (1) EP0253777B1 (es)
AT (1) ATE73326T1 (es)
DE (1) DE3777270D1 (es)
ES (1) ES2033341T3 (es)
GR (1) GR3004333T3 (es)
IT (1) IT1195852B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism

Also Published As

Publication number Publication date
EP0253777A2 (en) 1988-01-20
EP0253777B1 (en) 1992-03-11
GR3004333T3 (es) 1993-03-31
IT1195852B (it) 1988-10-27
EP0253777A3 (en) 1990-01-31
US4780308A (en) 1988-10-25
ATE73326T1 (de) 1992-03-15
IT8648228A1 (it) 1988-01-04
IT8648228A0 (it) 1986-07-04
DE3777270D1 (de) 1992-04-16

Similar Documents

Publication Publication Date Title
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DK275488D0 (da) Indolonderivater
EE02995B1 (et) 1,3-oksatiolaannukleosiidi analoogide kasutamine hepatiit B ravimpreparaatide valmistamiseks
DK358384A (da) Farmaceutiske midler til bekaempelse af diabetes mellitus
MX9207495A (es) Compuestos de tetrahidroisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ECSP034660A (es) Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen
HUP0004040A1 (hu) Antimikrobiális hatású pleuromutilinszármazékok, eljárás ezek előállítására, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
ES2053571T3 (es) Uso de propionato de fluticasona en la preparacion de una composicion farmaceutica para el tratamiento de enfermedades intestinales.
ES2059755T3 (es) Derivados organicos de hidrazina para uso farmaceutico.
ES2062443T3 (es) Nuevos derivados peptidicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2128043T3 (es) Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral.
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
KR890004705A (ko) 항바이러스성 제제
DE10075012I1 (de) Synergistin-Derivate deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
ES2077473T3 (es) Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ATE169922T1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
SE8903764D0 (sv) Lung protection agents
DE68922035D1 (de) Glyzerin-Derivat und dessen pharmazeutische Verwendung.
IT1195852B (it) Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati
DE69015072D1 (de) Naphthalen- und Tetrahydronaphthalen-gem-diphosphonat-Derivate.
LV10917A (lv) Bambuterina pielietojums lipidu saturu pazeminosu farmaceitisku kompoziciju pagatavosanai
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
IT1244373B (it) Composizioni farmaceutiche per uso orale contenenti eparina a basso peso molecolare, loro preparazione ed uso
ES2055121T3 (es) Procedimiento de preparacion de nuevos derivados trienicos de estructura cromenica, y los compuestos farmaceuticos que contienen estos derivados.
DK378087D0 (da) Tetracycliske indolderivater

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 253777

Country of ref document: ES